A federal investigation into Jim Irsay’s death raises serious concerns about medical oversight in addiction treatment.
FBI Scrutinizes Medical Practices in Irsay’s Death
In January 2026, the FBI initiated a federal investigation into the May 2025 death of Jim Irsay, former owner of the Indianapolis Colts, scrutinizing the role of Dr. Harry Haroutunian. This investigation centers on the prescription of controlled substances such as ketamine, raising alarm bells about the oversight of addiction treatment for high-profile individuals. Notably, despite the federal probe, no autopsy was conducted, with the medical examiner ruling Irsay’s death as non-sudden.
Dr. Haroutunian, a California addiction specialist, is under investigation for his prescribing practices, which reportedly involved opioids and ketamine. The grand jury has issued a subpoena, seeking documentation related to Irsay’s death and relationship with the doctor. This development underscores a critical examination of medical accountability, especially concerning addiction specialists and their management of controlled substances.
Historical Context of Irsay’s Substance Abuse
Jim Irsay, who became the youngest general manager in NFL history in 1984, had long battled with substance abuse. His struggles were public knowledge, with multiple overdoses and stints in rehab marking his later years. Despite these challenges, Irsay maintained his position until his untimely death in a Beverly Hills hotel room, with Dr. Haroutunian present.
His history of substance abuse and the circumstances surrounding his passing have reignited discussions about the responsibilities and ethical obligations of physicians treating addiction, especially when high-profile patients are involved. The absence of an autopsy raises further questions about the completeness of the death investigation.
Ongoing Investigation and Potential Implications
The Colts organization confirmed they have not been directly contacted by the FBI, with the investigation appearing to focus on individual conduct rather than the franchise. The FBI’s involvement suggests a serious inquiry into potential criminal actions, likely related to prescription violations. This could set a precedent for tighter regulations on addiction treatment practices, particularly concerning high-profile individuals.
The ongoing investigation may have broader implications for the medical community, potentially leading to more stringent oversight and accountability measures for addiction specialists. As the situation develops, Irsay’s family, the Colts organization, and the NFL are all stakeholders watching closely, with the potential for significant legal and industry-wide repercussions.
Sources:
ESPN: Colts acknowledge FBI probe into Irsay’s death
CBS Sports: FBI investigates doctor over Irsay’s death
Fox News: FBI probes Irsay’s death, focusing on doctor